UNIVPHOTO - Universus Photo
📢 Recent Corporate Announcements
Universus Photo Imagings reported a weak performance for Q3 FY26, with standalone revenue declining 20% YoY to ₹3.84 crore. The consolidated results were severely impacted by a ₹26.91 crore loss from its foreign associate, JPF Netherlands B.V., leading to a total consolidated net loss of ₹23.89 crore for the quarter. For the nine-month period, the company has swung to a massive consolidated loss of ₹66.87 crore, compared to a profit of ₹108.06 crore in the previous year. Standalone profitability also weakened, with EPS dropping to ₹2.74 from ₹4.19 YoY.
- Consolidated net loss of ₹23.89 crore reported for Q3 FY26.
- Standalone revenue from operations fell 20% YoY to ₹3.84 crore from ₹4.80 crore.
- Share of loss from foreign associate JPF Netherlands B.V. stood at ₹26.91 crore for the quarter.
- Nine-month consolidated performance reversed from a profit of ₹108.06 crore last year to a loss of ₹66.87 crore.
- Standalone Net Profit for the quarter decreased to ₹3.02 crore from ₹4.58 crore in the year-ago period.
Universus Photo Imagings reported a standalone net profit of ₹3.02 crore for Q3 FY26, a decline from ₹4.58 crore in the same quarter last year. On a consolidated basis, the company posted a net loss of ₹23.89 crore, primarily driven by a significant loss of ₹26.91 crore from its foreign associate, JPF Netherlands B.V. Total consolidated revenue for the quarter stood at ₹8.07 crore, down from ₹9.46 crore YoY. The nine-month consolidated performance shows a sharp swing to a loss of ₹66.87 crore compared to a profit of ₹108.06 crore in the previous year.
- Standalone revenue decreased 20% YoY to ₹3.84 crore from ₹4.80 crore.
- Consolidated net loss for Q3 FY26 stood at ₹23.89 crore, though narrowed from a loss of ₹88.98 crore in Q3 FY25.
- Share of loss from associate company JPF Netherlands B.V. impacted the bottom line by ₹26.91 crore this quarter.
- Nine-month consolidated loss reached ₹66.87 crore against a profit of ₹108.06 crore in the prior year period.
- Standalone EPS for the quarter dropped to ₹2.74 from ₹4.19 in the year-ago period.
Universus Photo Imagings Limited has responded to a clarification sought by the stock exchanges regarding the absence of segment-wise reporting in its financial results for the quarter ended September 30, 2025. The company clarified that its entire business activity falls under a single operating segment, which is 'Photo Films'. This response addresses the query raised by the exchanges on January 24, 2026, ensuring compliance with SEBI (LODR) Regulations. Since it is a single-segment company, separate segment reporting is not applicable.
- Exchange sought clarification on Jan 24, 2026, regarding missing segment details for the quarter ended Sept 30, 2025.
- Company officially confirmed it operates under a single business segment: Photo Films.
- Clarification was submitted to both NSE and BSE to comply with Regulation 33 of SEBI (LODR) Regulations, 2015.
- The response resolves the pending regulatory query regarding the Q2 FY26 financial disclosures.
Universus Photo Imagings Limited has filed its monthly compliance report regarding the re-lodgment of transfer requests for physical shares for December 2025. The company's Registrar and Share Transfer Agent, KFin Technologies Limited, confirmed that zero requests were received during this period. This filing is a mandatory regulatory requirement under the SEBI circular dated July 02, 2025. The report indicates no pending or processed physical share transfers for the month, reflecting a standard administrative update.
- Zero requests received for re-lodgment of physical share transfers during December 2025
- Compliance maintained with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97
- KFin Technologies Limited confirmed nil activity in the special window for physical transfers
- Average processing time for such requests remained at zero days due to lack of applications
Universus Photo Imagings Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by KFin Technologies Limited, confirms that all dematerialization requests received between October 1, 2025, and December 31, 2025, were processed within the stipulated 15-day period. This filing confirms that physical certificates were properly mutilated and the register of members was updated accordingly. Such filings are standard procedural requirements for all listed companies to ensure the integrity of electronic shareholding records.
- Compliance certificate submitted for the quarter ended December 31, 2025
- Registrar KFin Technologies confirmed processing of demat requests within 15 days
- Physical security certificates were mutilated and cancelled after verification
- Register of members updated with depository names for all approved demat requests
Universus Photo Imagings Limited has announced the closure of its trading window for all insiders and designated persons starting January 1, 2026. This move is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the upcoming financial disclosures. The window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and nine months ending December 31, 2025. This is a standard regulatory procedure to ensure market integrity before earnings announcements.
- Trading window for insiders to remain closed starting from Thursday, January 1, 2026
- Closure is related to the upcoming unaudited financial results for the quarter ending December 31, 2025
- Trading restriction will be lifted 48 hours after the official announcement of the financial results
- Compliance follows SEBI (Prohibition of Insider Trading) Regulations, 2015
Universus Photo Imagings Limited has approved the subscription to a rights issue of its associate company, JPF Netherlands B.V., at a price of Euro 3 per share. The target entity is a significant player in the BOPP and flexible packaging films industry, reporting a turnover of Euro 492.65 million for FY 2024-25. Universus currently maintains a 39.87% stake in the company, and this move ensures it maintains its strategic interest. The transaction is a cash consideration and is expected to be completed within the next 1-2 months.
- Subscription to rights issue of associate company JPF Netherlands B.V. at Euro 3 per share
- Target entity JPF Netherlands B.V. reported a turnover of Euro 492.65 million in FY 2024-25
- Universus Photo Imagings currently holds a 39.87% shareholding in the associate company
- The acquisition is a cash-based transaction expected to conclude within 1-2 months
Universus Photo Imagings Limited has submitted its monthly compliance report regarding the re-lodgment of transfer requests for physical shares for November 2025. This filing follows the SEBI circular dated July 02, 2025, which provides a special window for such transactions. The company's Registrar and Share Transfer Agent, KFin Technologies Limited, confirmed that zero requests were received during the month. As there were no requests, no approvals or rejections were processed, maintaining a status quo on physical share transfers.
- Zero (NIL) requests received for re-lodgment of physical share transfers in November 2025
- Compliance filing submitted as per SEBI Circular SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97
- KFin Technologies Limited confirmed the NIL status for the reporting period
- Average processing time for such requests was zero days due to lack of activity
Universus Photo Imagings Limited announced an update regarding the rights issue entitlement exercised by them in their associate company, JPF Netherlands B.V. JPFN allotted 39,86,968 equity shares to Universus Photo Imagings Limited as part of this rights issue. While the allotment occurred, the percentage of holding of Universus Photo Imagings Limited in JPFN remains unchanged. This announcement is in reference to the disclosure made on 27th August 2025 under Regulation 30(7) of SEBI (LODR) Regulation, 2015.
- JPF Netherlands B.V. allotted 39,86,968 equity shares to Universus Photo Imagings Limited.
- The allotment was related to the exercise of the right issue entitlement.
- The percentage of holding of the Company in JPF Netherlands B.V. remains unchanged.
Financial Performance
Revenue Growth by Segment
The Company operates in a single business segment: photographic products. Standalone revenue from this segment was INR 24.60 Cr (Rs. 2,459.60 Lakhs) for FY25. Total standalone income, which includes fair valuation gains, decreased by 4.99% YoY to INR 66.83 Cr (Rs. 6,682.79 Lakhs) from INR 70.34 Cr (Rs. 7,033.60 Lakhs) in FY24.
Profitability Margins
Standalone Net Profit Ratio improved significantly by 35.58%, rising from 95.19% in FY24 to 129.07% in FY25. This high margin is primarily driven by fair valuation gains on financial assets rather than core photographic sales. Consolidated Profit After Tax saw a massive recovery to INR 87.02 Cr (Rs. 8,701.50 Lakhs) in FY25 compared to a loss of INR 196.35 Cr (Rs. 19,634.80 Lakhs) in FY24, largely due to the share of profit from its associate company.
EBITDA Margin
The Operating Profit Margin (Profit before Depreciation and Tax) stood at 164.56% in FY25, representing a 31.89% YoY improvement from 124.77% in FY24, bolstered by non-operational financial asset gains.
Capital Expenditure
The company made a significant strategic investment of INR 125.19 Cr (Rs. 12,519 Lakhs) in Q2 FY26 by subscribing to a rights issue of its associate company, JPF Netherlands B.V., to maintain its shareholding and support international operations.
Credit Rating & Borrowing
Debt-Equity and Interest Coverage ratios are reported as 'NA' (Not Applicable), indicating the company operates with negligible or no long-term debt, which reduces financial risk in a shrinking core market.
Operational Drivers
Raw Materials
Photographic chemicals and film base materials used for X-Ray film manufacturing. Specific material names and their individual cost percentages are not disclosed.
Raw Material Costs
Standalone cost of materials consumed was INR 11.63 Cr (Rs. 1,163 Lakhs) for the year ended March 31, 2025, supporting the photographic segment revenue of INR 24.60 Cr.
Manufacturing Efficiency
Inventory turnover ratio improved by 13.86% to 2.78 times in FY25 (up from 2.45 times), indicating more efficient movement of stock and better alignment of production with declining demand.
Strategic Growth
Growth Strategy
The company plans to pivot by leveraging a thriving ecosystem of over 4,000 health-tech startups and supportive government initiatives. Growth is also pursued through its associate, JPF Netherlands B.V., evidenced by the INR 125.19 Cr investment in 2025 to sustain its international interests and potential diversified revenue streams.
Products & Services
Manufacturing, selling, and distributing X-Ray films for medical imaging.
New Products/Services
Management has identified the need to launch new products to sustain market presence, though specific product names or expected revenue contributions are not yet disclosed.
Market Expansion
The company is targeting growth through strategic innovation within the health-tech ecosystem, though specific regional targets are not detailed.
Strategic Alliances
Maintains a significant associate relationship with JPF Netherlands B.V. (JPFN), recently reinforced by a major capital infusion of INR 125.19 Cr.
External Factors
Industry Trends
The medical imaging industry is undergoing a massive shift from analog X-Ray films to digital technology. While the traditional business is shrinking, the company is looking toward the health-tech startup ecosystem for future positioning.
Competitive Landscape
The company faces competition from digital imaging providers and health-tech startups that offer film-less diagnostic solutions.
Competitive Moat
The company lacks a durable moat in its core business due to technological obsolescence. Sustainability depends entirely on the successful transition to new products or the performance of its financial investments and associates.
Macro Economic Sensitivity
Highly sensitive to shifts in global trade dynamics and economic circumstances, which require the company to maintain high adaptability to ensure sustained growth.
Consumer Behavior
Swift shifts in consumer and hospital preferences toward digital records are reducing the demand for physical X-Ray films.
Geopolitical Risks
The Russia-Ukraine conflict is specifically cited as a threat that introduces market uncertainties and challenges in maintaining regulatory compliance.
Regulatory & Governance
Industry Regulations
Operations are subject to evolving regulatory changes and compliance requirements in the medical products and photographic chemicals space.
Taxation Policy Impact
The standalone tax expense for FY25 was INR 8.60 Cr (Rs. 860 Lakhs), reflecting an effective tax rate of approximately 21.3% on Profit Before Tax.
Legal Contingencies
The company has disclosed the impact of pending litigations in Note 22 of its financial statements, though the specific aggregate value of these cases is not provided in the summary documents.
Risk Analysis
Key Uncertainties
The primary uncertainty is the viability of the X-Ray film business in a digital-first medical environment, which could lead to a total loss of core operational revenue if new products are not launched.
Technology Obsolescence Risk
High risk; the core product (X-Ray film) is being actively replaced by digital imaging technologies, necessitating a complete business model transformation.
Credit & Counterparty Risk
Debtors turnover ratio decreased by 16.66% to 14.87% in FY25, indicating a potential slowdown in payment collections from customers.